AIELLI, Federica
 Distribuzione geografica
Continente #
NA - Nord America 3.134
EU - Europa 2.189
AS - Asia 1.898
SA - Sud America 244
AF - Africa 26
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.502
Nazione #
US - Stati Uniti d'America 3.117
IE - Irlanda 634
CN - Cina 590
SG - Singapore 516
TR - Turchia 479
DE - Germania 283
HK - Hong Kong 232
RU - Federazione Russa 232
SE - Svezia 225
BR - Brasile 221
IT - Italia 207
UA - Ucraina 181
GB - Regno Unito 171
FI - Finlandia 96
FR - Francia 87
CZ - Repubblica Ceca 26
BE - Belgio 18
VN - Vietnam 18
CA - Canada 9
IN - India 8
IQ - Iraq 8
UZ - Uzbekistan 8
AU - Australia 7
JP - Giappone 7
TN - Tunisia 7
AR - Argentina 6
ES - Italia 6
KR - Corea 6
ZA - Sudafrica 6
BD - Bangladesh 5
EC - Ecuador 5
NL - Olanda 5
PK - Pakistan 5
RS - Serbia 5
CO - Colombia 4
EU - Europa 4
MA - Marocco 4
IL - Israele 3
JO - Giordania 3
KE - Kenya 3
MX - Messico 3
OM - Oman 3
PY - Paraguay 3
BO - Bolivia 2
DZ - Algeria 2
EG - Egitto 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
PE - Perù 2
AM - Armenia 1
AO - Angola 1
AT - Austria 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
EE - Estonia 1
KH - Cambogia 1
LT - Lituania 1
LU - Lussemburgo 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PL - Polonia 1
RO - Romania 1
VE - Venezuela 1
Totale 7.502
Città #
Jacksonville 720
Dublin 631
Chandler 602
Singapore 250
Hong Kong 231
Izmir 222
Boardman 201
Santa Clara 185
Nanjing 161
Wilmington 116
Ann Arbor 98
Lawrence 92
Princeton 92
San Mateo 88
Beijing 56
L'aquila 54
Shenyang 54
Moscow 52
Nanchang 51
New York 45
Bremen 41
Milan 39
Woodbridge 39
Seattle 37
Ashburn 34
Jinan 32
Tianjin 29
Mountain View 27
The Dalles 27
Brno 26
Düsseldorf 26
Kunming 25
Verona 25
Hebei 23
Dearborn 21
São Paulo 20
Des Moines 19
Brussels 18
Los Angeles 17
Zhengzhou 17
Helsinki 16
Jiaxing 16
Ningbo 15
Dong Ket 14
Changsha 13
Council Bluffs 13
Norwalk 13
Hangzhou 11
Guangzhou 10
London 10
Philadelphia 10
Tappahannock 10
Rome 9
Auburn Hills 8
Monza 8
Munich 8
Shanghai 8
Dallas 7
Falkenstein 7
Tashkent 7
Rio de Janeiro 6
Tokyo 6
Falls Church 5
Fortaleza 5
Fremont 5
Fuzhou 5
L’Aquila 5
Belo Horizonte 4
Frankfurt am Main 4
Johannesburg 4
Lanzhou 4
Pune 4
San Francisco 4
Taizhou 4
Washington 4
Belgrade 3
Caserta 3
Changchun 3
Curitiba 3
Edinburgh 3
Eschborn 3
Guarulhos 3
Houston 3
Jaú 3
João Pessoa 3
Jundiaí 3
Porto Alegre 3
Quito 3
Ribeirão das Neves 3
Salvador 3
Serra 3
Seveso 3
Toronto 3
Wuhan 3
Allston 2
Amman 2
Asunción 2
Baghdad 2
Baoding 2
Barcelona 2
Totale 4.894
Nome #
The supportive care task force at the University of L'Aquila: 2-years experience 148
Does pain intensity predict a poor opioid response in cancer patients? 141
Epidemiology and Characteristics of Episodic Breathlessness In Advanced Cancer Patients: An Observational Study 139
FRIENDLY & KIND with your health: Human-friendly knowledge-INtensive dynamic systems for the e-health domain 132
Attitudes of palliative home care physicians towards palliative sedation at home in Italy 125
Tapentadol in cancer pain management: a prospective open-label study 120
Efficacy and safety of deep, continuous palliative sedation at home: A retrospective, single-institution study 117
Age differences in the last week of life in advanced cancer patients followed at home 108
Efficacy of pregabalin in the management of cetuximab-related itch 103
Topical application of platelet supernatant gel in the management of radiotherapy-induced mucositis: a case report 101
Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients 99
Oncology together for L'Aquila: early resumption of integrated oncological activities after the earthquake 99
Background and episodic breathlessness in advanced cancer patients followed at home 99
Integrating oncology and palliative home care in Italy: the experience of the "L'Aquila per la Vita" Home Care Unit 98
Assessment and treatment of symptoms among italian medical oncologists 96
Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience 96
Pain evaluation and management: a survey of Italian radiotherapists 96
Breast cancer: dolore iatrogeno nelle pazienti con cancro della mammella durante il trattamento oncologico e nelle survivors 96
The frequency of alcoholism in patients with advanced cancer admitted to an acute palliative care unit and a home care program 95
Symptoms in advanced cancer: The influence of sex, age, Karnofsky Performance Status and PaP score. 93
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management 89
Cerebral metastasis from ovarian cancer treated with a multidisciplinary approach. Case report and review of literature 88
The use of low doses of a sublingual fentanyl formulation for breakthrough pain in patients receiving low doses of opioids 88
Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids 87
Gabapentin in the treatment of severe sweating experienced by advanced cancer patients 87
Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study 86
Low morphine doses in opioid-naive cancer patients with pain 85
Effective analgesic score: a "marker" of the effects of chemotherapy on pain in advanced cancer patients? 85
Sleep disturbances in advanced cancer patients admitted to a supportive/palliative care unit 85
Palliative care in advanced cancer patients: how and when? And where? 84
Breakthrough pain in oncology: A longitudinal study 84
The prevalence of constipation at admission and after 1 week of palliative care: a multi-center study 84
Safety and Effectiveness of Intravenous Morphine for Episodic Breakthrough Pain in Patients Receiving Transdermal Buprenorphine 84
Switching from Transdermal Drugs: An Observational "N of 1" Study of Fentanyl and Buprenorphine 83
Tools for Identifying Cancer Pain of Predominantly Neuropathic Origin and Opioid Responsiveness in Cancer Patients 83
Pain intensity as prognostic factor in cancer pain management 83
The effects of low doses of pregabalin on morphine analgesia in advanced cancer patients 83
Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases 83
Can malignant bowel obstruction in advanced cancer patients be treated at home ? 82
Dosing fentanyl buccal tablet for breakthrough cancer pain: Dose titration versus proportional doses 82
Breakthrough cancer pain in patients with abdominal visceral cancer pain 82
Sleep Disturbances in Patients with Advanced Cancer in Different Palliative Care Settings. 81
Pattern of symptoms and symptomatic treatment in adults and the aged population: A retrospective analysis of advanced cancer patients followed at home 81
Palliative sedation in patients with advanced cancer followed at home: A systematic review 81
Physical Exercise and Quality of Life in Breast Cancer Survivors 80
Effect of aging on pain relief in the older cancer patients: pharmacokinetic and pharmacodynamic aspects 80
The characteristics of advanced cancer patients followed at home, but admitted to the hospital for the last days of life 79
Validation of the pap score in advanced cancer patients who are candidates for palliative chemotherapy 79
Personalized Symptom Goals and Patient Global Impression on Clinical Changes in Advanced Cancer Patients 79
Low doses of transdermal fentanyl in opioid-naive patients with cancer pain 78
Hyoscine butylbromide for the management of death rattle: sooner rather than later 78
Prevalence of delirium in advanced cancer patients in home care and hospice and outcomes after 1 week of palliative care 78
The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting 77
Morphine in the treatment of incident pain triggered by vinorelbine infusion 76
Palliative sedation in advanced cancer patients followed at home: A retrospective analysis 76
Physicians' Attitudes Towards Euthanasia and Assisted Suicide In Italy 76
Factors influencing the clinical presentation of breakthrough pain in cancer patients 76
Choice of chemotherapy schedules in elderly patients (> 75 years) with metastatic colorectal cancer (mcrc) according to comorbidity 75
Characteristics of the case mix, organisation and delivery in cancer palliative care: a challenge for good-quality research 74
Rapid resolution of refractory chemotherapy induced oral mucositis with platelet gel-released supernatant in a pediatric cancer patient: a case report 73
Home care for cancer patients after an earthquake: the experience of the "L'Aquila per la Vita" Home Care Unit 73
Il trattamento del dolore nelle neoplasie ginecologiche 73
Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study 73
Pain Characteristics and Analgesic Treatment in an Aged Adult Population: A 4-Week Retrospective Analysis of Advanced Cancer Patients Followed at Home. 72
Fentanyl Pectin Nasal Spray Versus Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Comparative Study 72
Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: A 4-week, nonrandomized, open-label, uncontrolled observational study 72
Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS) 72
Symptom expression in advanced cancer patients admitted to hospice or home care with and without delirium 72
Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies. 71
Prognostic factors of survival in patients with advanced cancer admitted to home care 71
Palliative sedation in patients with advanced cancer followed at home: A prospective study 71
Knowledge and attitudes of Italian medical oncology residents toward the approach and treatment of pain 70
La terapia dei sintomi 69
Il trattamento dei sintomi principali nelle neoplasie ginecologiche 69
Breakthrough Pain in Patients with Lung Cancer. A Secondary Analysis of IOPS MS Study 68
Lipocalin 2 increases after high-intensity exercise in humans and influences muscle gene expression and differentiation in mice 68
Supporto nutrizionale 67
Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain 67
Orphan symptoms in advanced cancer patients followed at home 67
Bone metastasis pain, from the bench to the bedside 67
Opioids applied topically to painful cutaneous malignant ulcers in a palliative care setting 66
Prevalenza del dolore oncologico in fase precoce di malattia: risultati preliminari 65
The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy 65
Opioid switching in patients with advanced cancer followed at home. A retrospective analysis 64
Pruritus in a patient with advanced cancer successfully treated with continuous infusion of granisetron 64
Tumori Ginecologici 64
How do cancer patients receiving palliative care at home die? A descriptive study 63
Is there a role for neurologist in an oncological home care team? 62
Emergencies in patients with advanced cancer followed at home 62
L’importanza della valutazione dello stato nutrizionale nelle pazienti con neoplasie ginecologiche 59
Individualized Whole-Body Vibration: Neuromuscular, Biochemical, Muscle Damage and Inflammatory Acute Responses 59
Topical morphine in the treatment of painful ulcers 57
Totale 7.609
Categoria #
all - tutte 32.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.237


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020102 0 0 0 0 0 0 0 0 0 0 3 99
2020/2021748 19 93 0 98 92 23 103 4 95 28 154 39
2021/2022518 28 31 83 31 32 7 12 37 52 6 30 169
2022/20231.831 121 113 29 200 178 187 0 104 795 8 51 45
2023/2024313 57 24 13 43 24 75 4 12 1 21 9 30
2024/20251.764 44 36 142 108 321 178 301 156 372 88 18 0
Totale 7.609